Atlas Trials

Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis

Clinical trial NCT00263549 · COMPLETED

Trial details

NCT number
NCT00263549
Sponsor
Allergopharma GmbH & Co. KG
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
House Dust Mite Allergy
Start date
2002-09-01
Primary completion
2005-02-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.